RTHM

About:

Transforming care for complex illness, starting with Long COVID

Top Investors: Y Combinator

Description:

RTHM is a biotechnology company that combines remote clinical medicine and research with advanced molecular and digital measurement technologies to bring new diagnostics and treatments to patients faster.

Total Funding Amount:

$2.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Redwood City, California, United States

Founded Date:

2018-01-01

Contact Email:

support(AT)rthm.com

Founders:

Jennifer Curtin, Ryan Kellogg

Number of Employees:

11-50

Last Funding Date:

2022-05-18

IPO Status:

Private

Industries: